Physician profile
Danielle M Sutton
NPI 1528427796
$2,891.96
in general payments reported to CMS, 2019-2025
17 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.48 · 2022: $197 · 2023: $1,803 · 2024: $526 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341 · Travel and Lodging: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.10 |
| Travel and Lodging | $1,271.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,653.91 | 2023 | Myfembree |
| Novo Nordisk INC | $367.96 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $177.38 | 2021-2025 | |
| Amgen INC. | $174.20 | 2024 | |
| Phathom Pharmaceuticals, INC. | $128.52 | 2024 | Voquezna |
| Lilly USA, LLC | $102.24 | 2021-2025 | Zepbound, Mounjaro |
| Astellas Pharma US INC | $77.24 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $32.93 | 2024 | |
| Idorsia Pharmaceuticals US INC | $32.01 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $23.62 | 2025 | Thinprep 2000 Processor, Aptima |
| Therapeuticsmd, INC. | $21.32 | 2021 | |
| Exact Sciences Corporation | $21.27 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $18.89 | 2022 | |
| Organon LLC | $16.91 | 2025 | Nexplanon |
| Lucid Diagnostics INC. | $15.30 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $14.79 | 2025 | NP Thyroid 60 |
| Janssen Pharmaceuticals, INC | $13.47 | 2023 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.